You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
Title |
Early versus deferred androgen suppression in the treatment of advanced prostatic cancer
|
---|---|
Published in |
Cochrane database of systematic reviews, October 2001
|
DOI | 10.1002/14651858.cd003506 |
Pubmed ID | |
Authors |
Timothy J Wilt, Bijay Nair, Roderick MacDonald, Indy Rutks |
Abstract |
Prostate cancer is a leading cause of cancer death in men. Treatment goals for men with advanced prostate cancer include prolonging survival, preventing or delaying symptoms due to disease progression, improving and maintaining quality of life, reducing treatment related morbidity. Androgen suppression therapy is considered a mainstay of treatment for men with advanced prostate cancer. However it is not clear whether early androgen suppression for men with locally advanced disease or asymptomatic metastases improves length and quality of life compared to androgen suppression deferred until signs and symptoms of clinical progression. |
Mendeley readers
The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 2 | 2% |
United Kingdom | 2 | 2% |
Italy | 1 | <1% |
Spain | 1 | <1% |
United States | 1 | <1% |
Unknown | 104 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 17 | 15% |
Other | 14 | 13% |
Student > Ph. D. Student | 14 | 13% |
Researcher | 12 | 11% |
Student > Doctoral Student | 11 | 10% |
Other | 25 | 23% |
Unknown | 18 | 16% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 58 | 52% |
Nursing and Health Professions | 4 | 4% |
Agricultural and Biological Sciences | 3 | 3% |
Computer Science | 2 | 2% |
Decision Sciences | 2 | 2% |
Other | 9 | 8% |
Unknown | 33 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 March 2021.
All research outputs
#8,571,053
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#9,070
of 11,499 outputs
Outputs of similar age
#15,639
of 45,762 outputs
Outputs of similar age from Cochrane database of systematic reviews
#13
of 24 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 45,762 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.